|
TP53BP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.80990003381976E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.3483999999897E-06 |
| Normal-vs-Stage2 |
9.90880000000249E-05 |
| Normal-vs-Stage3 |
5.8225000376666E-09 |
| Normal-vs-Stage4 |
3.68840000000148E-05 |
| Stage1-vs-Stage2 |
5.214200E-01 |
| Stage1-vs-Stage3 |
3.285800E-02 |
| Stage1-vs-Stage4 |
6.582600E-01 |
| Stage2-vs-Stage3 |
3.648600E-01 |
| Stage2-vs-Stage4 |
8.152800E-01 |
| Stage3-vs-Stage4 |
1.904580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.79559999985624E-07 |
| Normal-vs-AfricanAmerican |
3.360100E-03 |
| Normal-vs-Asian |
4.802800E-01 |
| Caucasian-vs-AfricanAmerican |
6.163000E-01 |
| Caucasian-vs-Asian |
1.626050E-01 |
| AfricanAmerican-vs-Asian |
4.553400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.24199991905039E-10 |
| Normal-vs-Female |
1.021940E-04 |
| Male-vs-Female |
4.115600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.099650E-03 |
| Normal-vs-Age(41-60Yrs) |
4.86119999998369E-06 |
| Normal-vs-Age(61-80Yrs) |
3.15900000047442E-07 |
| Normal-vs-Age(81-100Yrs) |
8.32299999999897E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.222800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.052400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.638800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.206210E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.369500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.701820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.353000E-01 |
| Normal-vs-Grade 2 |
1.81859999948131E-07 |
| Normal-vs-Grade 3 |
1.75090000054112E-07 |
| Normal-vs-Grade 4 |
1.21159999999509E-06 |
| Grade 1-vs-Grade 2 |
5.245600E-02 |
| Grade 1-vs-Grade 3 |
4.707600E-02 |
| Grade 1-vs-Grade 4 |
1.770320E-02 |
| Grade 2-vs-Grade 3 |
4.983800E-01 |
| Grade 2-vs-Grade 4 |
2.961800E-01 |
| Grade 3-vs-Grade 4 |
6.299400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.45519999997335E-06 |
| Normal-vs-ccB subtype |
4.41540000000185E-05 |
| ccA subtype-vs-ccB subtype |
5.950800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.171099999839E-07 |
| Normal-vs-N1 |
7.681500E-02 |
| N0-vs-N1 |
5.935800E-01 |
|
|
